Company intelligence / Profile preview
PlantForm Corporation
- Ownership
- Private
- Development stage
- Preclinical
Overview
PlantForm has developed a proprietary plant-based expression platform, vivoXPRESS®, which enables rapid, low-cost production of monoclonal antibodies and therapeutic proteins. Their technology can reduce manufacturing costs by up to 90% compared to traditional systems and cut development timelines to as little as six weeks. The company’s pipeline includes programs in cancer, infectious diseases such as HIV/AIDS and Ebola, anti-toxins like anti-ricin antibodies, and diagnostic reagents for avian influenza. Some biosimilar candidates have shown equivalence with reference products in preclinical studies.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Therapeutic proteinsVaccines
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on PlantForm Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PlantForm Corporation.